Free Trial

Myomo Q4 2023 Earnings Report

Myomo logo
$6.12 +0.03 (+0.49%)
(As of 12/20/2024 05:31 PM ET)

Myomo EPS Results

Actual EPS
-$0.07
Consensus EPS
-$0.05
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Myomo Revenue Results

Actual Revenue
$4.76 million
Expected Revenue
$4.70 million
Beat/Miss
Beat by +$60.00 thousand
YoY Revenue Growth
N/A

Myomo Announcement Details

Quarter
Q4 2023
Time
N/A
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Myomo Earnings Headlines

Myomo 3M share Spot Secondary priced at $5.00
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Myomo dips on $15M equity offering
See More Myomo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Myomo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Myomo and other key companies, straight to your email.

About Myomo

Myomo (NYSEAMERICAN:MYO), a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

View Myomo Profile

More Earnings Resources from MarketBeat

Upcoming Earnings